ICU beds to be increased, plasma therapy to continue in Delhi, says Jain

Amid a surge in Covid-19 cases in Delhi, Kejriwal has directed authorities to increase the number of ICU beds and take steps to contain the spread of the infection, Health Minister Satyendar Jain said

Satyendra Jain
Satyendra Jain, cabinet minister in Aam Aadmi Party (AAP)-led Delhi government
Press Trust of India New Delhi
3 min read Last Updated : Sep 10 2020 | 3:54 PM IST

Amid a surge in COVID-19 cases in Delhi, Chief Minister Arvind Kejriwal has directed authorities to increase the number of ICU beds in hospitals and take steps to contain the spread of the infection, Health Minister Satyendar Jain said on Thursday.

Interacting with reporters, he also said plasma therapy will continue to be used in Delhi as it is proving to be effective in people who are in stage one or two of COVID-19 treatment, but not in stage three or those on ventilators.

He told this to mediapersons when asked to respond about an Indian Council of Medical Research-funded study which has found that use of convalescent plasma therapy in coronavirus-infected patients does not help in reducing mortality or progression to severe COVID-19 stage.

The chief minister had on Wednesday held a review meeting with Jain, Chief Secretary Vijay Dev, senior officials and medical superintendents of Delhi government-run hospitals and asked them to take all possible steps to prevent the spread of virus.

"The meeting was held to assess the current situation of COVID-19 and medical superintendents of all hospitals were present in it. The main outcome of the meeting was that CM has directed authorities to increase the number of ICU beds (in hospitals)," Jain said.

Delhi reported 4,039 fresh COVID-19 cases on Wednesday, the highest single-day spike so far, as thetally breached the two lakh-mark in the city. On Wednesday, a record 54,517 tests were conducted by authorities in 24 hours, the health bulletin had said.

This was the first time since the outbreak of the pandemic, that over 4,000 cases were recorded in Delhi in a day. The previous highestsingle-day spike of 3,947 cases was recorded on June 23.

Twenty fatalities were recorded in the last 24 hours taking the death toll to 4,638, according to the bulletin issued on Wednesday.

"Delhi recorded highest spike in cases so far. But, it is also because we have gone aggressive on testing, with over 54,000 tests, highest ever in Delhi. And, we had set a target of 40,000 tests per day. So, we do not want to to leave any infected person in tracing," Jain told reporters.

Out target is to ensure "zero mortality" and treatment protocols have been standardised, he added.

The positivity rate on Wednesday was 7.4 per cent which is close to the corresponding figure at a national level (7.5 per cent), Jain said.

On the ICMR-funded study, which has not yet been peer-reviewed and has appeared on medRxiv, a pre-print server, the health minister asked whether the ICMRhas said it is wrong.

Plasma therapy has been in use for many decades for various diseases. As of now there is no standard treatment for COVID-19. And, patients in ICU, who are in first two stages, it is proving effective on them, he said.

"I myself am a COVID survivor and was administered plasma therapy, so I am telling," he said, adding, that roughly 1,000 patients have been administered the therapy in Delhi.

On the provision to getting tests done without any doctor's prescription, Jain said an AADHAAR card or any other identify proof will do. For RT-PCR, AADHAAR card will be required, he said.

Jain also held a meeting with medical directors and medical superintendents of all Delhi government hospitals on Wednesday to review the status of testing, the bulletin had said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusDelhiSatyendra Jain

First Published: Sep 10 2020 | 3:51 PM IST

Next Story